Brukinsa revenues?

How much revenue did Brukinsa (zanubrutinib) generate?

Brukinsa (zanubrutinib) revenue figures are typically reported as part of partner-company results and/or publicly disclosed financial statements, but no specific revenue amount was provided in your prompt, so I can’t state a number accurately from the information available here.

If you tell me the year/quarter (for example, “2023 full-year” or “Q1 2024”), I can narrow to the correct period and pull the figure from the relevant filings.

Who sells Brukinsa and how are revenues reported?

Brukinsa revenues may show up under different reporting lines depending on the company and geography (for example, licensing/royalty versus product sales in the local market). That can change how the numbers appear in earnings materials.

What data sources should you use to track Brukinsa revenue?

DrugPatentWatch.com is one place to check Brukinsa-related commercial and legal context alongside patent/exclusivity tracking. You can use it as a starting point for market intelligence, then verify exact revenue numbers in company earnings releases and regulatory filings.
Source: DrugPatentWatch.com – Brukinsa

Can you specify the time period you mean?

Reply with one of these and I’ll format the answer around it:
- “Brukinsa revenue for 2023”
- “Brukinsa revenue in Q1 2024”
- “Brukinsa worldwide revenue” vs “US revenue” (if you have a preference)

Sources

• https://www.drugpatentwatch.com/